REGENXBIO INC's ticker is RGNX and the CUSIP is 75901B107. A total of 173 filers reported holding REGENXBIO INC in Q2 2021. The put-call ratio across all filers is 0.22 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $124,000 | +1.6% | 3,732 | 0.0% | 0.02% | +14.3% |
| Q4 2021 | $122,000 | -26.5% | 3,732 | -6.0% | 0.02% | -30.0% |
| Q3 2021 | $166,000 | +7.8% | 3,971 | 0.0% | 0.03% | +25.0% |
| Q2 2021 | $154,000 | +14.1% | 3,971 | 0.0% | 0.02% | +4.3% |
| Q1 2021 | $135,000 | -25.0% | 3,971 | 0.0% | 0.02% | -25.8% |
| Q4 2020 | $180,000 | +65.1% | 3,971 | 0.0% | 0.03% | +55.0% |
| Q3 2020 | $109,000 | -25.3% | 3,971 | 0.0% | 0.02% | -23.1% |
| Q2 2020 | $146,000 | +13.2% | 3,971 | 0.0% | 0.03% | -7.1% |
| Q1 2020 | $129,000 | -20.9% | 3,971 | 0.0% | 0.03% | -6.7% |
| Q4 2019 | $163,000 | +15.6% | 3,971 | 0.0% | 0.03% | +7.1% |
| Q3 2019 | $141,000 | +6.8% | 3,971 | +54.5% | 0.03% | +16.7% |
| Q2 2019 | $132,000 | -10.2% | 2,571 | 0.0% | 0.02% | -7.7% |
| Q1 2019 | $147,000 | – | 2,571 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aquilo Capital Management, LLC | 1,167,684 | $28,842,000 | 9.84% |
| Sonic Fund II, L.P. | 193,079 | $4,769,000 | 2.91% |
| ArchPoint Investors | 253,181 | $6,254,000 | 2.48% |
| Redmile Group, LLC | 2,004,663 | $49,515,000 | 1.89% |
| Sofinnova Investments, Inc. | 776,624 | $19,183,000 | 1.60% |
| RTW INVESTMENTS, LP | 1,845,366 | $45,581,000 | 1.18% |
| WS MANAGEMENT LLLP | 416,997 | $10,300,000 | 0.84% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 104,129 | $2,572,000 | 0.79% |
| HARBOR CAPITAL ADVISORS, INC. | 30,251 | $747,000 | 0.57% |
| Atom Investors LP | 36,487 | $901,000 | 0.39% |